Murine inducible nitric oxide (NO) synthase (iNOS) is catalytically active only in dimeric form. Assembly of its purified subunits into a dimer requires H4B. To understand the structure-activity relationships of human iNOS, we constitutively expressed recombinant human iNOS in NIH 3T3 cells by using a retroviral vector. These cells are deficient in de novo H4B biosynthesis and the role of H4B in the expression and assembly of active iNOS in an intact cell system could be studied. In the absence of added H4B, NO synthesis by the cells was minimal, whereas cells grown with supplemental H4B or the H4B precursor sepiapterin generated NO (74.1 and 63.3 nmol of nitrite per 106 cells per 24 h, respectively). NO synthesis correlated with an increase in intracellular HAB but no increase in iNOS protein. Instead, an increased percentage of dimeric iNOS was observed, rising from 20% in cytosols from unsupplemented cells to 66% in H4B-supplemented cell cytosols. In all cases, only dimeric iNOS displayed catalytic activity. Cytosols prepared from H4B-deficient cells exhibited little iNOS activity but acquired activity during a 60-to 120-min incubation with H4B, reaching final activities of 60-72 pmol of citrulline per mg of protein per min. Reconstitution of cytosolic NO synthesis activity was associated with conversion of monomers into dimeric iNOS during the incubation. Thus, human iNOS subunits dimerize to form an active enzyme, and H4B plays a critical role in promoting dimerization in intact cells. This reveals a posttranslational mechanism by which intracellular H4B can regulate iNOS expression.
increased percentage of dimeric iNOS was observed, rising from 20% in cytosols from unsupplemented cells to 66% in H4B-supplemented cell cytosols. In all cases, only dimeric iNOS displayed catalytic activity. Cytosols prepared from H4B-deficient cells exhibited little iNOS activity but acquired activity during a 60-to 120-min incubation with H4B, reaching final activities of 60-72 pmol of citrulline per mg of protein per min. Reconstitution of cytosolic NO synthesis activity was associated with conversion of monomers into dimeric iNOS during the incubation. Thus, human iNOS subunits dimerize to form an active enzyme, and H4B plays a critical role in promoting dimerization in intact cells. This reveals a posttranslational mechanism by which intracellular H4B can regulate iNOS expression. H4B is synthesized from GTP and was first shown to function as an essential cofactor for the aromatic amino acid hydroxylases (1) (2) (3) . Subsequent reports of H4B synthesis in cells lacking these enzymes (4) and of increased H4B production during immunostimulation (5) suggested that other H4B-requiring enzymes must exist. This was confirmed when the nitric oxide synthases (NOSs) were found to require H4B for maximum activity (6) (7) (8) (9) (10) . Three NOS isoforms have been purified and cloned from several sources. All appear to be homodimeric enzymes that convert L-arginine to nitric oxide (NO) and L-citrulline (for reviews, see refs. 11 and 12) . In addition to containing iron protoporphyrin IX (heme), FAD, and FMN, purified rat neuronal NOS and NOS isolated from cytokine-induced mouse macrophages [inducible NOS (iNOS)] both incorporate variable amounts (0.1-1 mol/mol of subunit) of tightly bound H4B (13, 14) . Their ability to maintain bound H4B during purification is consistent with a slow dissociation rate of H4B from NOS (15) and may explain why purified NOSs carry out limited NO synthesis even in the absence of added H4B (8, 16) .
Although roles have begun to emerge for FAD, FMN, and heme in NOS electron transfer and NO synthesis (11, 17) , the The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
catalytic function of H4B remains unclear. Early studies argued against H4B acting as a simple electron donor (18, 19) . In addition, H4B does not function in NOS as it does in aromatic amino acid hydroxylation where one H4B binds to the enzyme during each catalytic cycle, participates in oxygen activation and substrate hydroxylation, and is then released in an oxidized form (20) . While H4B can be envisioned to carry out similar redox chemistry in NO synthesis (21) , studies have been unable to detect redox cycling of H4B in NOS (19, 22) .
In contrast to its elusive redox function, a role for H4B in forming and maintaining NOS structure seems well established. H4B enables L-arginine to bind to NOS (15) , stabilizes the axial ligand geometry of the NOS heme iron (23) , and induces purified iNOS subunits to associate into an active dimeric enzyme (24) . Subunit association in this system also required L-arginine and heme and may be functionally important in that iNOS subunits lack catalytic activity prior to dimerization (24) .
Although the work with purified subunits is compelling, a role for H4B in iNOS subunit dimerization in intact cells has yet to be established. This is experimentally difficult because many cells either contain sufficient H4B to promote dimerization (D.J.S., unpublished results) or their iNOS expression and H4B biosynthesis are coinduced in response to cytokines (5) . Also, to our knowledge, no reports have specifically examined human iNOS to establish that it is dimeric, how dimeric structure is related to catalytic activity, and whether H4B participates in this process. This is an important issue given that human iNOS expression has been implicated in the pathogenesis of diseases including inflammatory bowel disease and diabetes mellitus (25, 26) . Despite an 80% sequence homology between mouse and human iNOSs, differences in their transcriptional control and cofactor requirements (i.e., calmodulin; ref. 27) do exist and prevent extrapolations regarding structure-function relationships.
To address these issues, we stably expressed human iNOS in NIH 3T3 cells, a murine fibroblast cell line that was determined to be deficient in H4B biosynthesis. This report describes how H4B affects human iNOS protein expression, subunit interaction, and catalytic function within these engineered cells.
MATERIALS AND METHODS
Retroviral Vectors and Replication-Deficient Retrovirus. The recombinant human iNOS cDNA was cloned in our laboratory from cytokine-stimulated cultured human hepatocytes as described (27) . It Proc. Natl. Acad. Sci. USA 92 (1995) retroviral vector (28) (31) . RNAs were also collected from cells treated for 24 h with interferon y (IFN--y, 250 units/ml), shown to induce GTP cyclohydrolase I (GTP-CH I) in murine dermal fibroblasts (32) . RNAs (20 ,ug) were electrophoresed and probed with a 2.3-kb fragment of the human iNOS cDNA as described (31) or a 700-bp fragment of rat GTP-CH I (provided by K. Hatakeyama, University of Pittsburgh, Pittsburgh) that hybridizes with murine GTP-CH I mRNA. Cytokine-stimulated human hepatocyte RNA served as a positive control for native human iNOS mRNA. 18S rRNA controlled for relative RNA loading.
Nitrite (NO-) Measurements. Cells were passaged to 24-well plates. The next day, the cell medium was replaced with medium alone or medium with H4B (100 ,uM; B. Shircks, Switzerland), with Nw-methyl-L-arginine (L-NMA; 0.5 mM) + H4B, with sepiapterin (SEP; 50 ,uM; B. Shircks), with SEP + L-NMA, with SEP + methotrexate (MTX; 25 ,M), with H4B + MTX, or with MTX alone. Accumulated NO2 in the supernatants was quantified with the Griess reaction (33) using sodium nitrite as standard. SEP is a pterin analog that is converted to H4B by dihydrofolate reductase (DHFR) (20) , and MTX is a potent inhibitor of DHFR (34, 35) . H4B and SEP concentration responses were also examined in DFGiNOS cells at concentrations ranging from 10-10 to 10-4 M.
iNOS Activity in Cell Cytosols. DFGiNOS cells were resuspended in protease inhibitor buffer [20 mM Tes, pH 7.4/2 mM dithiothreitol/10% (vol/vol) glycerol/antipain (25 gg/ml)/ aprotinin (25 ,tg/ml)/leupeptin (25 ,tg/ml)/chymostatin (25 ,ug/ml)/50 ,M phenanthroline/pepstatin A (10 ,ug/ml)/100 ,tM phenylmethylsulfonyl fluoride] with 10 ,M FMN and 10 ,uM FAD. The cytosol was isolated as described (36) SDS/PAGE and Western Blot Analysis. Cytosolic proteins (100 j,g) were separated by SDS/PAGE on 8% gels, as described (38) . Human hepatocytes were isolated and cultured as described (31) . Cytosol from human hepatocytes 12 h after stimulation with interleukin 1/3 at 5 units/ml, tumor necrosis factor a at 500 units/ml, IFN-,y (100 units/ml), and lipopolysaccharide at 10 (Fig. 1 ) was performed. A 7.5-kb iNOS signal was detected in DFGiNOS cells that was absent from both uninfected and BaglacZ cells. This signal corresponded with the expected size of the polycistronic DFGiNOS transcript and was easily distinguished from the 4.5-kb endogenous iNOS mRNA found in stimulated hepatocytes of either human or rodent origin. The absence of the 4.5-kb signal in all NIH 3T3 cell groups signified that these cells did not express native murine iNOS under normal culture conditions. GTP-CH I is the rate-limiting enzyme for the H4B biosynthetic pathway (5) . No GTP-CH I message could be detected in control or DFGiNOS-infected NIH 3T3 cells (data not shown). In addition, stimulation of these cells with IFN-,y, which coinduces iNOS and GTP-CH I in murine dermal fibroblasts (32), failed to induce either iNOS (Fig. 1) NO2 production by DFGiNOS cells was increased in a concentration-dependent manner by both H4B and SEP ( Fig.  2) with half-maximal stimulation of iNOS catalytic activity occurring at 10-7 M and 10-9 M, respectively. This was in accordance with the H4B affinity of 0.4 ,tM measured for porcine brain NOS (8) . The 100-fold difference in efficacy between H4B and SEP may reflect the need for H4B to be oxidized to 7,8-dihydrobiopterin before it can be efficiently taken up by cells (10) .
To understand how H4B increased iNOS activity in DFGiNOS cells, we first determined whether H4B availability influenced human iNOS protein concentrations. Western blot analysis of cytosols prepared from cells cultured with (H4B+) or without (H4B-) 100 ,uM H4B for 24 h showed that iNOS protein levels were not altered by H4B addition (Fig. 3) . This argued against H4B augmenting expression of the iNOS protein or preventing its degradation. There was no evidence of iNOS protein in uninfected or BaglacZ cells (data not shown). Because subunit dimerization is required for purified mouse iNOS to synthesize NO (24), we next examined whether H4B supplementation functioned to increase dimerization of human iNOS in the cells. Cytosols were prepared from DFGiNOS cells cultured with or without H4B, equal amounts of protein were fractionated by gel filtration chromatography, and the iNOS protein content and NO synthesis activity of each fraction were determined. Western blot analysis of the gel filtration fractions revealed that the majority of iNOS protein in cytosol from H4B-cells was in monomeric form (Fig. 4A) . In contrast, the majority of iNOS in H4B+ cytosol was eluted at a size consistent with dimeric enzyme (24) . Analysis of the band intensity by densitometry revealed an estimated monomeric to dimeric iNOS ratio of 4:1 in the H4B-cytosols but a 1:2 ratio in the H4B+ cytosols (Fig. 4B) . A small proportion of dimeric iNOS was present in the H4B-cytosols. Corresponding iNOS activity measurements of the column fractions ( I"-Lh.
Proc. Natl. Acad. Sci. USA 92 (1995) 11775 becomes active by assembling into a dimer, and this reaction is promoted by H4B in the intact cell. Our current results with human iNOS are consistent with work that identified a role for H4B in the dimerization of purified mouse iNOS subunits in vitro (24) . In that report, mouse iNOS subunits were inactive regarding NO synthesis but assembled into active dimers when incubated for 60-90 min with H4B, L-arginine, and a stoichiometric amount of heme. Dimer formation correlated with a proportional gain in NO synthesis activity in all cases. Omission of H4B reduced mouse iNOS subunit dimerization significantly ('80%) but not completely (24) and is consistent with the low but detectable levels of dimeric human iNOS found in the H4B-deficient NIH 3T3 cells. In contrast to the murine iNOS studies, human iNOS could dimerize in cytosols supplemented with H4B alone. However, this may reflect the presence of cytosolic heme and L-arginine rather than an independence toward these factors. Thus, our current work establishes a common structural role for H4B in promoting iNOS subunit assembly in both mouse and human. Despite only an 80% homology between murine and human iNOS (27) , the amino acid variations do not lead to differences in H4B action and suggest that subunit dimerization is a common post-translational control mechanism for iNOS.
While H4B availability clearly dictated cellular assembly of human iNOS, it did not affect the steady-state concentrations of iNOS protein. In addition, growing cells in the absence of H4B did not prevent conversion of their inactive monomers to active dimers upon subsequent H4B supplementation to the cell cytosol. These findings suggest that H4B is not required for proper iNOS protein folding and discount a role for iNOS dimeric structure in mediating protein stability or resistance to proteolytic degradation in cells.
NIH 3T3 cells do not express GTP-CH I and were incapable of de novo H4B biosynthesis. However, the DFGiNOStransduced cells exhibited a slight but significant elevation in NO-production compared to control NIH 3T3 cells, contained some dimeric iNOS, and sometimes contained detectable cytosolic biopterin concentrations. Their low biopterin content may be attributed to cellular uptake of pterins from serum used in the culture medium (10) . Whether these low intracellular H4B concentrations are enough to support the observed levels of subunit dimerization and NO synthesis is unknown and, thus, requires further study.
SEP, a metabolic precursor of H4B (20) , also supported NO synthesis by the engineered NIH 3T3 cells. The effects of SEP and H4B were abolished by the DHFR inhibitor MTX. H4B is unstable at physiologic pH in oxygenated solution (10) and rapidly decomposes in 7,8-dihydrobiopterin, which is the likely species entering the cells in culture. Because DHFR can convert 7,8-dihydrobiopterin or SEP to H4B (20) , this enzyme appears to play a critical role in generating intracellular H4B from exogenous SEP or H4B in NIH 3T3 cells.
GTP-CH I is coinduced in many cells that express iNOS in response to immunoactive cytokines (5, 32, 39) . Our current data suggest that coinduction of these enzymes ensures sufficient H4B for efficient assembly of iNOS into its active dimeric form. It is remarkable that a link evolved between intracellular H4B levels and cellular assembly of iNOS. This structural role for H4B is distinct from its possible function as a redox component in the catalysis of NO synthesis. The biopterindeficient cell system described here provides a tool to further investigate the influence of H4B on iNOS enzymology and may lead to the development of pharmacologic agents that interrupt specific interactions between iNOS and H4B.
